DMII (Drugs Made In America Acquisition II) 5-Year Share Buyback Ratio: 0.00% (As of Mar. 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II 5-Year Share Buyback Ratio?

Drugs Made In America Acquisition II DMII 15 5-Year Share Buyback Ratio is 0.00 as of Mar. 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 122 Diversified Financial Services companies, Drugs Made In America Acquisition II ranks worse than 819671.31% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Drugs Made In America Acquisition II's current 5-Year Share Buyback Ratio was 0.00%.

DMII's 5-Year Share Buyback Ratio is not ranked *
in the Diversified Financial Services industry.
Industry Median: -3.3
* Ranked among companies with meaningful 5-Year Share Buyback Ratio only.

Drugs Made In America Acquisition II (NAS:DMII) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Drugs Made In America Acquisition II 5-Year Share Buyback Ratio Related Terms

DMII vs BCSS, EVAC, CEPF: 5-Year Share Buyback Ratio Comparison

For the Shell Companies subindustry, Drugs Made In America Acquisition II's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Drugs Made In America Acquisition II 5-Year Share Buyback Ratio vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Drugs Made In America Acquisition II's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Drugs Made In America Acquisition II's 5-Year Share Buyback Ratio falls into.


DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
5-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 5-Year Share Buyback Ratio of 0.00 mean?
Drugs Made In America Acquisition II (DMII) has a 5-Year Share Buyback Ratio of 0.00 as of Mar. 2026. The 5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. View historical data for Drugs Made In America Acquisition II and its competitors. According to the industry distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 122 companies in the Diversified Financial Services industry.
Is Drugs Made In America Acquisition II's 5-Year Share Buyback Ratio too high?
Drugs Made In America Acquisition II's current 5-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 122 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's 5-Year Share Buyback Ratio compare to BCSS and EVAC?
According to the Diversified Financial Services industry distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 122 companies for 5-Year Share Buyback Ratio. This places Drugs Made In America Acquisition II in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Share Buyback Ratio for a Diversified Financial Services company?
A good 5-Year Share Buyback Ratio depends on the Diversified Financial Services industry context. However, 5-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Share Buyback Ratio mean?
A high 5-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. View historical data for Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current 5-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current 5-Year Share Buyback Ratio of 0.00. The current 5-Year Share Buyback Ratio is 0.00. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Share Buyback Ratio calculated?
5-Year Share Buyback Ratio is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current 5-Year Share Buyback Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

5-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price